Fiona Eatock, President BAETS
Marcin Barczyński, President PCES

1. • Marek Ruchała (Poznań, PL): Active Surveillance for Papillary Thyroid Microcarcinoma (15 min)
   • George Moucholis (Stevenage, UK): Thermal Ablation for Papillary Thyroid Microcarcinoma (15 min)
   • Iain Nixon (Edinburgh, UK): Surgery for low-risk DTC (15 min) Awaiting confirmation
   • Agnieszka Czarniecka (Gliwice, PL): Management of intermediate-risk DTC (15 min)
   • Marek Dedecjus (Warsaw, PL): Management of advanced DTC (15 min)

• Kwapisz M, DlugosinskaJ, Januszkiewicz-Caulier J, Dworakowska A, Galczynski J, Góralski P, Gorzelnik A, Dedecjus M (Warsaw, PL): Tracheostomy for airway compromise in anaplastic thyroid carcinoma: Survival outcomes and clinical utility in a single-centre retrospective cohort. (Abstract ID: 111)
• Budzynska M, Gajoch I, Krakowska K, Konturek A, Barczynski M (Kraków, PL): Beyond thyroidectomy: Gut microbiota changes during differentiated thyroid cancer treatment – a systematic review. (Abstract ID: 113)
• Budzynska M, Krakowska K, Konturek A, Barczynski M (Kraków, PL): Thermal ablation for Bethesda III-IV thyroid nodules: Is the current level of evidence sufficient to justify changes in clinical practice? (Abstract ID: 118)

1. • Susannah Shore (Liverpool, UK) How to assess risk of malignancy? (15 min)
   • Aleksandra Gilis-Januszewska (Kraków, PL) How to define and manage mild autonomous cortisol secretion (MACS)? (15 min)
   • Piotr Myśliwiec (Białystok, PL) Who should have surgical treatment and how should it be performed? (15 min)
   • Peter Truran (Newcastle, UK) What follow-up is indicated if the adrenal incidentaloma is not surgically removed? (15 min)

• Kurzawinski TR, Sanders K, Chung TT, Abdel-Aziz T, Rosalen-Garcia V, Bosch K, Mihai R, Dickinson L, Anderson C, Arstad E, Buhidma Y, Awais RO, Sirindil F, Shortman R, O'Keeffe AG, Dickson J, Brown MJ, Williams B (London, Nottingham, Oxford, UK): Adrenal Aldosterone Synthase Expression Imaging with ¹⁸FAldoView correctly predicts lateralisation of abnormal Aldosterone secretion in patients with Primary Aldosteronism. (Abstract ID: 65)
• Vanalia P, Costa Silva A, Safwaan A, Ho J, Gulamhusein A (Manchester, UK): Day-Case Robotic Adrenalectomy Within An Enhanced Recovery Programme: A Single Centre Experience. (Abstract ID: 83)
• Parikh RP, Bosch KB, Khan SK, Mihai RM (Oxford, UK): Can Robotic Adrenalectomy Improve Service Delivery? (Abstract ID: 51)

• Xu N, Khoo R, Occhiuzzi F, Latella D, Volpini L (Blackpool, Southampton, UK; Catanzaro, IT): Evaluation of the effect of Intra-operative Tranexamic Acid in Thyroid Surgery - A systematic Review and Meta-analysis. (Abstract ID: 1)
• Baig H, Khan Q, Shah F, Lucocq J, Watson C (Glasgow, Aberdeen, UK): Botulinum Toxin A for Improving Anterior Neck Scar Outcomes After Thyroid and Parathyroid Surgery: A Systematic Review. (Abstract ID: 74)
• Choi K, Kim SK, Lee YM (Seoul, KR): Comparison of single-port robotic and laparoscopic posterior retroperitoneal adrenalectomy: the shifting impact of tumor size on operative efficiency. (Abstract ID: 33)
• Iscan Y, Karatas I, Sormaz IC, Aksakal N, Tunca F, Senyurek Y (Istanbul, TR): Continuous Versus Intermittent Intraoperative Neuromonitoring in Thyroid Surgery: A Single-Center Analysis of 4,008 Nerves at Risk. (Abstract ID: 131)
• Watts E, Chander N, BAETS Collaborative Authorship, Sharma N (Birmingham, London, UK): Peri-Operative Management of Graves’ Disease Undergoing Total Thyroidectomy: A National BAETS Survey of UK Practice. (Abstract ID: 4)
• Abdelsalam A, Eddama M, Rozalin-Garcia V, Kurzawinski T, Abdel-Aziz T (London, UK): Clinical Improvement After Adrenalectomy for Primary Aldosteronism: External Validation of the PADSS Score. (Abstract ID: 12)
• Bosch KD, Parikh R, Lau J, Fraser SM, Mihai R, Khan S, De Jong MC (Oxford, Leeds, UK): Adrenalectomy in the Elderly: Increased Frailty Without Worse Outcomes. (Abstract ID: 92)
• Agilinko JA, Bawa JH, Moonim MT, Tolley NS, Palazzo FF, Jarvis S, Bevan CL, Di Marco AN (London, UK): Beyond Diagnostic Accuracy: Are Molecular Classifiers Clinically Interchangeable? Insights from Hierarchical Meta-analysis and Computational Outcome Modelling in 4,377 Indeterminate Thyroid Nodules. (Abstract ID: 107)
• Ahmad H, MacFaul W, Stechman M, Scott-Coombes D, Patel N (Cardiff ,UK): Parathyroidectomy with intraoperative PTH for Primary hyperparathyroidism: A single centre 10 year follow up experience. (Abstract ID: 66)

• Alternative access for retroperitoneal paraganglioma as a good operative option. (Abstract ID: 96)
• Transoral Robotic Resection of retorpharyngeal PTC node. (Abstract ID: 139)
• Robotic Excision of a Paraganglioma Using a Supine Approach: Technical Nuances and Advantages. (Abstract ID: 84)
• Intraoperative neuromonitoring in recurrent goitre. (Abstract ID: 91)

Speakers:

• Witold Chudziński (Warsaw, PL) Diagnosis of Primary Hyperparathyroidism – Redefining Biochemical and Clinical Boundaries (10 min)
• Małgorzata Trofimiuk-Müldner (Kraków, PL) Preoperative localization in PHPT (10 min)
• Neil Sharma (Birmingham, UK) Surgical Management – Who Should Be Operated and When? (10 min)
• Alicja Hubalewska-Dydejczyk (Kraków, PL) Non-Surgical Management – Medical Therapy vs Thermal Ablation vs Active Surveillance (10 min)
• Neil Gittoes (Birmingham, UK) Long-Term Outcomes – What Do We Know and What Remains Unclear? (10 min)
• Discussion (10 min)

• Gittoes N, Palermo A, Rejnmark L, Khan A, Schwarz P, Hofbauer L, Cetani F, Jain R, Clarke B, Zhao C, Shu A, Rubin M (Birmingham, UK; Rome, IT; Aarhus, DK; Hamilton, CA; Copenhagen, DK; Dresden, DE; Pisa, IT; Chicago, New Yok, USA): Five-Year Data Report From the Phase 2 PaTH Forward Trial of Palopegteriparatide for Adults With Hypoparathyroidism. (Abstract ID: 11)
• Gawrychowska-Janicka A, Bronikowska J, Czuba Z, Gawrychowski J (Zabrze, PL): The effect of vitamin D3 on proinflammatory cytokines in women with primary hyperparathyroidism before and after parathyroidectomy (PTX). (Abstract ID: 59)
• Sadiq AA, Zammit C (Brighton, UK): A systematic review assessing long-term health-related quality of life after parathyroidectomy in patients with primary hyperparathyroidism. (Abstract ID: 42)

Quan Yang-Duh (San Francisco, USA)

Introduction: Marcin Barczynski (Kraków, PL)

• Barczyński M, Kołodziejska K, Krakowska K, Dworak M, Konturek A (Kraków, PL): Low dose indocyanine green probe-based quantification of parathyroid vascularity: A comparative study with standard dose camera-based fluorescence angiography. (Abstract ID: 44)
• Patel AP, Janicki JL, Rostkowska OR, Śledziński MS, Hellmann AH (Gdańsk, PL): Neuromuscular blockade protocol for effective intraoperative neuromonitoring in thyroid surgery: a systematic review. (Abstract ID: 22)
• Gkrinia E, Karamitsou P, Brown J, Gagen H, Rajaguru K, Mochloulis G, Dimitriadis P (Stevenage, UK): Thermal Ablation of Benign Thyroid Nodules: The Lister Hospital Experience. (Abstract ID: 64)
• Krakowska K, Krężołek M, Kulesa-Mrowiecka M, Konturek A, Barczyński M (Kraków, PL): Postoperative changes in muscle stiffness and quality of life after thyroid and/or parathyroid surgery: A pilot study. (Abstract ID: 68)

• Abdulwahid, Dr. Abdullah (Sulaimanyah, Iraq): Reclassifying TRAb-Negative Hyperthyroidism: Highlighting a Large-Volume–Driven Phenotype. (Abstract ID: 9)
• Morales D, Fernandez JL, Soler R, Bregoli N, Dominguez MD, Monje C, Perez L, Plata G, Peix M, Ocana LT (Malaga, Spain): Prophylactic Central Lymph Node Dissection in Patients with Bethesda V FNA: Discussion is Opened. (Abstract ID: 34)
• O'Brien AOB, Ionescu AI, Sheahan PS (Cork, Ireland): Intraoperative Autofluorescence Imaging for Parathyroid Preservation in Total Thyroidectomy: A Retrospective Analysis. (abstract ID: 43)

Speakers:

• Case 1: Beata Kos-Kudła (Katowice, PL)
• Case 2: Tarek Abdul-Aziz (London, UK)
• Case 3: Anna Sowa-Staszczak (Kraków, PL)
• Case 4: Helen Doran (Manchester, UK)

Speakers:

• James Kirkby-Bott (Southampton, UK), Sid Nagala (Reading, UK): Artificial Intelligence in Endocrine Surgery: From Decision Support to Autonomous Systems (12 min)
• Klaudia Proniewska (Krakow, PL): High‑resolution 3D visualization of endocrine organs with emphasis on thyroid, parathyroid, and adrenal tumors—a new platform for medical education, mixed/virtual reality, and computational simulation (12min)
• Marco Raffaelli (Rome, IT): Simulation-Based Training in Endocrine Surgery: Current Standards and Future Directions (12 min)
• Özer Makay (Izmir, TR): Educational Strategies for TOETVA and Robotic Thyroidectomy: Building Competence in Novel Approaches (12 min)
• Discussion (12 min)

Fiona Eatock, President BAETS
Marcin Barczyński, President PCES